These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9024493)

  • 1. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population.
    Mison LM; Young IF; O'Donoghue M; Cowley N; Thorlton N; Hyland CA
    Transfusion; 1997 Jan; 37(1):73-8. PubMed ID: 9024493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors.
    Craxì A; Valenza M; Fabiano C; Magrin S; Fiorentino G; Diquattro O; Pagliaro L
    J Hepatol; 1994 Nov; 21(5):730-4. PubMed ID: 7890886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
    Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
    Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
    Pawlotsky JM; Bastie A; Pellet C; Remire J; Darthuy F; Wolfe L; Sayada C; Duval J; Dhumeaux D
    J Clin Microbiol; 1996 Jan; 34(1):80-3. PubMed ID: 8748278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase.
    Prince AM; Scheffel JW; Moore B
    Transfusion; 1997 Feb; 37(2):211-4. PubMed ID: 9051098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L; Nousbaum JB; Elghouzzi MH; Giral P; Legendre C; Poupon R
    Hepatology; 1995 Mar; 21(3):725-9. PubMed ID: 7875670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus (HCV) genotype analysis in apparently healthy anti-HCV-positive Parisian blood donors.
    Stuyver L; Fretz C; Esquivel C; Boudifa A; Jaulmes D; Azar N; Lunel F; Leroux-Roels G; Maertens G; Fournel JJ
    Transfusion; 1996 Jun; 36(6):552-8. PubMed ID: 8669089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay.
    Lee SR; Wood CL; Lane MJ; Francis B; Gust C; Higgs CM; Nelles MJ; Polito A; DiNello R; Achord D
    Transfusion; 1995 Oct; 35(10):845-9. PubMed ID: 7570915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype.
    Dow BC; Munro H; Buchanan I; Follett EA; Davidson F; Yap PL; Simmonds P
    Transfusion; 1996 Jun; 36(6):547-51. PubMed ID: 8669088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.
    Cano H; Candela MJ; Lozano ML; Vicente V
    Transfus Med; 2003 Oct; 13(5):259-66. PubMed ID: 14617336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
    Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
    Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of hepatitis C virus genotypes among blood donors from mid-west region of Brazil.
    Martins RM; Teles SA; Freitas NR; Motta-Castro AR; Souto FJ; Mussi A; Amorim RM; Martins CR
    Rev Inst Med Trop Sao Paulo; 2006; 48(1):53-5. PubMed ID: 16547582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients.
    Vrielink H; Reesink HW; van den Burg PJ; Zaaijer HL; Cuypers HT; Lelie PN; van der Poel CL
    Transfusion; 1997 Aug; 37(8):845-9. PubMed ID: 9280331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
    Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
    Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.